siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells (original) (raw)

References

• Agami R . (2002). Curr. Opin. Chem. Biol., 6, 829–834.
• Brummelkamp TR, Bernards R and Agami R . (2002a). Cancer Cell, 2, 243–247.
• Brummelkamp TR, Bernards R and Agami R . (2002b). Science, 296, 550–553.
• Butz K, Denk C, Ullmann A, Scheffner M and Hoppe-Seyler F . (2000). Proc. Natl. Acad. Sci. USA, 97, 6693–6697.
• Butz K, Geisen C, Ullmann A, Zentgraf H and Hoppe-Seyler F . (1998). Oncogene, 17, 781–787.
• Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A and Hoppe-Seyler F . (1995). Oncogene, 10, 927–936.
• Chen C and Okayama H . (1987). Mol. Cell. Biol., 7, 2745–2752.
• Chomczynski P and Sacchi N . (1987). Anal. Biochem., 162, 156–159.
• Cole ST and Danos O . (1987). J. Mol. Biol., 193, 599–608.
• Elbashir SM, Harboth J, Lendeckel W, Yalcin A, Weber K and Tuschl T . (2001). Nature, 411, 494–498.
• Elbashir SM, Harboth J, Weber K and Tuschl T . (2002). Methods, 26, 199–213.
• El-Deiry WS, Tokino T, Velculescu VE, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . (1993). Cell, 75, 817–825.
• Evan GI and Vousden KH . (2001). Nature, 411, 342–348.
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC . (1998). Nature, 391, 806–811.
• Fulda S, Wick W, Weller M and Debatin M . (2002). Nat. Med., 8, 808–815.
• Funk WD, Pak DT, Karas RH, Wright WE and Shay JW . (1992). Mol. Cell. Biol., 12, 2866–2871.
• Goodwin EC and DiMaio D . (2000). Proc. Natl. Acad. Sci. USA, 97, 12513–12518.
• Hoppe-Seyler F and Butz K . (1999). Anticancer Res., 19, 4747–4758.
• Igney FH and Krammer PH . (2002). Nat. Rev. Cancer, 2, 277–288.
• Jaque J-M, Triques K and Stevenson M . (2002). Nature, 418, 435–438.
• Jiang M and Milner J . (2002). Oncogene, 21, 6041–6048.
• Lee NS, Dohjima T, Bauer G, Li H, Li M-J, Ehsani A, Salvaterra P and Rossi J . (2002). Nat. Biotechnol., 19, 500–505.
• Mantovani F and Banks L . (2001). Oncogene, 20, 7874–7887.
• Mittnacht S . (1998). Curr. Opin. Genet. Dev., 8, 21–27.
• Morris MC, Chaloin L, Heitz F and Divita G . (2000). Curr. Opin. Biotechnol., 11, 461–466.
• Münger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M and Zacny VL . (2001). Oncogene, 20, 7888–7898.
• Nicholson DW . (2000). Nature, 407, 810–816.
• Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee S-K, Collman RG, Lieberman J, Shankar P and Sharp PA . (2002). Nat. Med., 8, 681–686.
• Paddison PJ and Hannon GJ . (2002). Cancer Cell, 2, 17–23.
• Pan H and Griep AE . (1994). Genes Dev., 9, 2157–2169.
• Parkin DM, Bray FI and Devesa SS . (2001). Eur. J. Cancer, 37, S4–S66.
• Reed JC . (2001). Trends Mol. Med., 7, 314–319.
• Rittner K, Benavente A, Bompard-Sorlet A, Heitz F, Divita G, Brasseur R and Jacobs E . (2002). Mol. Ther., 5, 104–114.
• Rothbard JB, Garlington S, Lin Q, Kirschberg T, Kreider E, McGrane PL, Wender P and Khavari PA . (2000). Nat. Med., 11, 1253–1257.
• Salvesen GS and Duckett CS . (2002). Nat. Rev. Mol. Cell. Biol., 3, 401–410.
• Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM . (1990). Cell, 63, 1129–1136.
• Schneider-Gaedicke A and Schwarz E . (1986). EMBO J., 5, 2285–2292.
• Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR and Schiller JT . (1991). J. Virol., 65, 4860–4866.
• Smotkin D, Prokoph H and Wettstein FO . (1989). J. Virol., 63, 1441–1447.
• Southern PJ and Berg P . (1982). J. Mol. Appl. Genet., 1, 327–341.
• Thomas M and Banks L . (1998). Oncogene, 17, 2943–2954.
• Thomas M and Banks L . (1999). Oncogene, 18, 7690–7700.
• Venturini F, Braspenning J, Homann M, Gissmann L and Sczakiel G . (1999). Nucleic Acids Res., 27, 1585–1592.
• von Knebel Doeberitz M, Oltersdorf T, Schwarz E and Gissmann L . (1988). Cancer Res., 48, 3780–3786.
• Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD and Howley PM . (2000). EMBO J., 19, 5762–5771.
• Zur Hausen H . (2002). Nat. Rev. Cancer, 2, 342–350.

Download references